Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-30

FDA Approved: REMERON — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for REMERON (mirtazapine) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remeron (mirtazapine)

Snippet

SUPPL AP for REMERON (MIRTAZAPINE)